*  Advances in Combination Tumor Immunotherapy | Frontiers Research Topic
The purpose of this Research Topic is to highlight recent advances in combination tumor immunotherapy and provide insight into ... Having established this unique capacity of immunotherapy to mediate such durable melanoma tumor rejections, the focus of the ... This trial demonstrated the feasibility and potential therapeutic efficacy of combination immunotherapy for the treatment of ... Recent clinical studies have highlighted the therapeutic efficacy of cancer immunotherapy, such as T cell immune checkpoint ...
  https://www.frontiersin.org/research-topics/2886/advances-in-combination-tumor-immunotherapy
*  2017 Forecast - cancer immunotherapies Global Market, Industry Size, Share, Analysis and Opportunities to 2023. | Market...
Cancer Immunotherapy has brought an unprecedented change in the global cancer therapies market. Cancer immunotherapy can be ... Over the past few years, cancer immunotherapies have generated new waves of optimism in the global oncology market, unveiling ... The key factors driving the global cancer immunotherapy's market are rising incidences of cancer, minimal or no side effects ... 2017 Forecast - cancer immunotherapies Global Market, Industry Size, Share, Analysis and Opportunities to 2023. ...
  http://beforeitsnews.com/market-research-reports/2017/03/2017-forecast-cancer-immunotherapies-global-market-industry-size-share-analysis-and-opportunities-to-2023-258.html
*  Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis - Full Text View - ClinicalTrials...
A history of allergen immunotherapy in the previous 10 years, or in the previous 3 years for pre-seasonal immunotherapy ... At present, the efficacy of immunotherapy (peptide or otherwise) can only be established at the conclusion of therapy. The aim ... Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis. Further study details as ... Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis. This study has been completed. ...
  https://clinicaltrials.gov/ct2/show/NCT01383590
*  Post-Doctoral Scientist, Sotomayor Lab
His primary area of research is immunobiology and immunotherapy of B-cell malignancies, with special emphasis on the design of ...
  https://www.gwu.jobs/postings/47893
*  Cancer Immunotherapy Market Sales Segmentation with Manufacturers, Types, Application and Growth Analysis by Regions from 2016...
Global Cancer Immunotherapy Market research report is a professional and in-depth study on the current state of the Cancer ... Cancer Immunotherapy Market is expected to witness growth of international market with respect to advancements and innovations ... The global Cancer Immunotherapy market consumption for major regions is given. Additionally, type wise and application wise ... Also, the Cancer Immunotherapy market growth in various regions and R&D status are also covered. ...
  http://www.abnewswire.com/pressreleases/cancer-immunotherapy-market-sales-segmentation-with-manufacturers-types-application-and-growth-analysis-by-regions-from-2016-to-2021_83165.html
*  Study suggests immunotherapy may help overcome trastuzumab-resistance in breast cancer - EPM Magazine
... have suggested that immunotherapy may help to overcome trastuzumab-resistant breast cancer. ... PANACEA study immunotherapy combination trastuzumab breast cancer International Breast Cancer Study Group (IBCSG) HER2-positive ... A significant amount of preclinical and correlative clinical data suggest that such cases could be amenable to immunotherapy." ... Home News Study suggests immunotherapy may help overcome trastuzumab-resistance in breast cancer ...
  https://www.epmmagazine.com/news/study-suggests-immunotherapy-may-help-overcome-trastuzumab-r/
*  Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses | JEM
Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses. Byron H. Kwan, Eric F. Zhu, Alice Tzeng, ... Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses. View ORCID ProfileByron H. Kwan, Eric F. ... Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment. Curr. Opin. Immunol. 25:268-276 ... Raising the bar: the curative potential of human cancer immunotherapy. Sci. Transl. Med. 4:127ps8. doi:10.1126/scitranslmed. ...
  http://jem.rupress.org/content/early/2017/05/03/jem.20160831
*  Step 11: Immunotherapy | Nicklaus Children's Hospital
Step 11: Immunotherapy *NO TITLE. Immunotherapy is like a vaccination against your allergies. Vaccine shots are to prevent ... Risks involved with immunotherapy. Since immunotherapy involves the injection of something that you are allergic to, there is a ... With the advice of your allergist, you can decide if immunotherapy is right for you. Do the benefits of immunotherapy outweigh ... You should not receive immunotherapy if you are taking beta-blocker medication. Beta-blockers counteract the effects of ...
  https://www.nicklauschildrens.org/care-guides/step-11-immunotherapy
*  Types of cancer Immunotherapy Archives »
Immunotherapy and Side Effects Immunotherapy is one of the most exciting areas of new discoveries and treatments for many ... Tag: Types of cancer Immunotherapy. What Is Cancer Immunotherapy and Types, Side Effects. *Health ... Understanding Immunotherapy Immunotherapy is a broad category of anti-cancer therapies that use the body's immune system to ... What Is Cancer Immunotherapy Immunotherapy is treatment that uses certain parts of a person's immune system to fight ...
  http://selectoday.com/tag/types-of-cancer-immunotherapy/
*  Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD). - Full Text View - ClinicalTrials.gov
Drug: HAART + Immunotherapy Patients assigned to this arm will receive Trizivir + Kaletra + cyclosporin A during the first two ... Experimental: HAART + Immunotherapy Patients assigned to this arm will receive HAART plus cyclosporin A during the first two ...
  https://clinicaltrials.gov/show/NCT00979706?order=260
*  Understanding Immunotherapy and Cancer Immunotherapy Archives »
Tag: Understanding Immunotherapy and Cancer Immunotherapy. Understanding Immunotherapy and Cancer Immunotherapy. *Health ... Understanding Immunotherapy Immunotherapy is a broad category of anti-cancer therapies that use the body's immune system to ... What Is Cancer Immunotherapy Immunotherapy is treatment that uses certain parts of a person's immune system to fight ...
  http://selectoday.com/tag/understanding-immunotherapy-and-cancer-immunotherapy/
*  World Immunotherapy Congress USA 2017 - ADC Review ADC Review
That's why World Immunotherapy Congress is coming to the USA after an acclaimed launch in Europe. This inaugural event will ... Co-located with the Americas Antibody Congress, Immunotherapy World Congress USA features 2 days of in-depth case studies and ... The demand for innovation in immunotherapy can only grow, and new breakthroughs are needed if success rates are to continue. ... government and academia to build on the development and commercialization of new immunotherapy treatments. ...
  https://adcreview.com/events/world-immunotherapy-congress-usa-2017/
*  Cancer Vaccines : Pharmaceuticals : UK
13:30 Individualised mRNA cancer immunotherapy. Ludwig Heesen, Project Manager, BioNTech AG. View Bio. Ludwig Heesen studied ... Stephanie McArdle is at the head of T-cell vaccine immunotherapy, which is mainly focused on the validation of novel ... Stephanie McArdle is at the head of T-cell vaccine immunotherapy, which is mainly focused on the validation of novel ... Alfredo is CEO of Nouscom AG, a biotech company dedicated to the development of next generation immunotherapies to beat cancer ...
  http://www.smi-online.co.uk/pharmaceuticals/uk/conference/cancer-vaccines
*  HON - News : Immune-Based Therapy Shows Early Promise Against MS
The approach is known as "adoptive" immunotherapy, where a patient's own immune system T cells are genetically tweaked to fight ...
  http://www.hon.ch/News/HSN/721885.html
*  Immunotherapy
... About Immunotherapy. Immunotherapy, also known as targeted therapy or biotherapy, is a promising new cancer ... Types of Immunotherapy. The aim of immunotherapy is to boost the immune system through the use of:. *active therapies, which ... Non-specific immunotherapies. Unlike cancer vaccines, which are very specific to certain cells, non-specific immunotherapies ... Several types of immunotherapies from these two classes currently are in use or being studied by researchers, including:. ...
  http://kidshealth.org/en/parents/immunotherapy.html?view=ptr&WT.ac=p-ptr
*  Immunology and Immunotherapy | SpringerLink
Lode HN, Reisfeld RA (2000) Targeted cytokines for cancer immunotherapy. Immunol Res 21:279-288CrossRefPubMedGoogle Scholar ... 2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 188:22-32CrossRefPubMed ... 1999) Immunotherapy of human tumors with T-cell-activating bispecific antibodies: stimulation of cytotoxic pathways in vivo. ... 2002) Targeted alpha particle immunotherapy for myeloid leukemia. Blood 100:1233-1239PubMedGoogle Scholar ...
  https://link.springer.com/chapter/10.1007/3-540-26616-X_14
*  Immunotherapy - Wikipedia
... while immunotherapies that reduce or suppress are classified as suppression immunotherapies. In recent years, immunotherapy has ... Immunotherapy may produce long-term benefits. Immunotherapy is partly effective in some people and ineffective in others, but ... Immunotherapy is the "treatment of disease by inducing, enhancing, or suppressing an immune response". Immunotherapies designed ... "immunotherapies definition". Dictionary.com. Retrieved 2009-06-02. "Immunotherapy , Memorial Sloan Kettering Cancer Center". ...
  https://en.wikipedia.org/wiki/Immunotherapy
*  immunotherapy | Research!America
The more researchers know about how different therapies work and for whom they work, the faster they can make progress in finding treatments, said Dr. William Nelson, director of Johns Hopkins Kimmel Cancer Center during a panel discussion on March 8 about precision medicine moderated by The Washington Post's Laurie McGinley. The discussion was part of Johns Hopkins Medicine's On the Road to Precision Medicine Health Care Leader Series , which explores topics of cost, communication, research, and health care delivery in relation to precision medicine. Regarding concerns that the drug approval process is too lengthy, Nelson said that the efficiency achieved by focusing on creating targeted ...
  http://www.researchamerica.org/blog-tags/immunotherapy
*  Specific Immunotherapy (01.03.2013)
The mechanism of action of specific immunotherapy. Until a few years ago, specific immunotherapy was thought to exert its ... 0.73 for subcutaneous immunotherapy (SCIT) and −0.49 for sublingual immunotherapy (SLIT); the corresponding mean differences in ... Specific Immunotherapy. Indications and Mode of Action. Dtsch Arztebl Int 2013; 110(9): 148-58; DOI: 10.3238/arztebl.2013.0148 ... Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997; 99: 450 3. MEDLINE ...
  https://www.aerzteblatt.de/int/archive/article?id=134932
*  Personalized cancer immunotherapy
... No. 09a , 01/03/2017 , by Koh The new Helmholtz Institute HI-TRON is a collaboration of the ... Up to now, little is known why immunotherapies are effective in some patients and fail in others. Therefore, another major aim ... The goal of the partnership is to develop effective immunotherapies and to identify novel biomarkers for assessing the ... In recent times, physicians have achieved spectacular clinical successes with cancer immunotherapies. There have even been ...
  https://www.dkfz.de/en/presse/pressemitteilungen/2017/dkfz-pm-17-09a-Personalized-cancer-immunotherapy.php
*  Making immunotherapy more effective
Cancer immunotherapy has come of age. The idea of harnessing the immune system to fight cancer has already moved from the lab ... While most immunotherapy research has focused on how antibodies' arms "reach out" and bind to immune checkpoint proteins, Dr. ... But cancer immunotherapy isn't for all patients: only a minority of patients, suffering from specific cancer types, respond ... He and his colleagues initiated cancer immunotherapy using existing drugs that target the immune activation protein CD40 in ...
  http://www.weizmann.ac.il/WeizmannCompass/print/583
*  Immunotherapy (journal) - Wikipedia
Immunotherapy is a peer reviewed medical journal covering immunology and more specifically immunotherapy. It was established in ... "Immunotherapy". NLM Catalog. National Center for Biotechnology Information. Retrieved 2014-12-13. "Content overview". Scopus. ...
  https://en.wikipedia.org/wiki/Immunotherapy_(journal)
*  Cancer immunotherapy - Wikipedia
What is Cancer Immunotherapy Association for Immunotherapy of Cancer Society for Immunotherapy of Cancer "And Then There Were ... Cancer immunotherapy (Immuno-oncology or Onco-immunology) is the use of the immune system to treat cancer. Immunotherapies can ... Active immunotherapy directs the immune system to attack tumor cells by targeting TAAs. Passive immunotherapies enhance ... Many cancer immunotherapy drugs, including PD-1 and PD-L1 inhibitors, are antibodies. For example, immune checkpoint blockers ...
  https://en.wikipedia.org/wiki/Cancer_immunotherapy
*  Allergen immunotherapy - Wikipedia
Sublingual immunotherapy is also found to have a better safety profile than subcutaneous immunotherapy since the local side ... The guidelines acknowledge that sublingual immunotherapy is safer than subcutaneous immunotherapy. World Allergy Organisation ... production and quality of immunotherapy products with a view to register allergen immunotherapy as pharmaceutical specialties. ... Oral immunotherapy (OIT) involves giving the allergen by mouth. Its balance of risk to benefit for food allergies is not well ...
  https://en.wikipedia.org/wiki/Allergen_immunotherapy
*  Active immunotherapy - Wikipedia
Active immunotherapy, Mantle cell lymphoma#Immunotherapy, "Heat-shock protein vaccines as active immunotherapy against human ... Active immunotherapy is a type of immunotherapy that attempts to stimulate the host's intrinsic immune response to a disease e. ... Specific Active Immunotherapy: The generation of cell-mediated and antibody immune responses focused on specific antigens ... It divides into: Non-Specific Active Immunotherapy: Generating a general immune system response using cytokines and other cell ...
  https://en.wikipedia.org/wiki/Active_immunotherapy